Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 10-2014 | 10-2013 | 10-2012 | 10-2011 | 10-2010 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 0 | 0 | 1 | 0 | 0 |
| Accounts receivable | 21 | -21 | -26 | -37 | -17 |
| Other Working Capital | 127 | -52 | -133 | 34 | -41 |
| Other Operating Activity | 32 | -172 | -121 | 51 | -94 |
| Operating Cash Flow | $179 | $-245 | $-279 | $48 | $-152 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -192 | 0 | -2 | 0 | 0 |
| Investing Cash Flow | $-192 | $0 | $-2 | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | 0 | -200 | N/A | N/A |
| Common Stock Issued | N/A | 0 | 1,000 | N/A | N/A |
| Common Stock Repurchased | N/A | N/A | -12 | N/A | N/A |
| Financing Cash Flow | $N/A | $0 | $788 | $N/A | $N/A |
| Exchange Rate Effect | 36 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 339 | 583 | 76 | 28 | 179 |
| End Cash Position | 362 | 339 | 583 | 76 | 28 |
| Net Cash Flow | $-12 | $-245 | $508 | $48 | $-152 |
| Free Cash Flow | |||||
| Operating Cash Flow | 179 | -245 | -279 | 48 | -152 |
| Capital Expenditure | -192 | N/A | -2 | N/A | 0 |
| Free Cash Flow | -12 | -245 | -280 | 48 | -152 |